The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the virus, and those older than age 65.

However, this process is now in question based on statements from Trump administration officials. The statements come amid a delay in a decision on whether to approve the COVID-19 vaccine made by ...

redirecting the money to a single vaccine project linked to the Trump administration's former acting head of the National Institutes of Health. Multiple federal health officials said they were ...

Health care has proved a vulnerable target for the firehose of cuts and policy changes President Donald Trump ordered in the name of reducing waste and improving efficiency. But most of the impact isn’t as tangible as, say, higher egg prices at the grocery store.

Pennsylvania health officials are facing down ... The grants were created to help these agencies during the COVID-19 pandemic, but the Trump administration says they are obsolete.

Hatfill, a virologist and White House adviser during President Donald ... vaccines,” Inglesby said. As health officials searched for treatments while the coronavirus spread, the debate over ...

Pennsylvania health officials are facing a potential ... The grants were created to help these agencies during the COVID-19 pandemic, but the Trump administration says they are obsolete.

COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.